Immunometabolism in Pediatric Obesity

CompletedOBSERVATIONAL
Enrollment

82

Participants

Timeline

Start Date

April 25, 2019

Primary Completion Date

February 5, 2021

Study Completion Date

June 30, 2024

Conditions
ObesityType 2 Diabetes MellitusInsulin Resistance
Trial Locations (1)

72202

Arkansas Children's Research Institute, Little Rock

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

collaborator

University of Arkansas

OTHER

lead

Arkansas Children's Hospital Research Institute

OTHER

NCT03960333 - Immunometabolism in Pediatric Obesity | Biotech Hunter | Biotech Hunter